KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fulgent Genetics (FLGT) Income from Non-Controlling Interests (2021 - 2025)

Fulgent Genetics' Income from Non-Controlling Interests history spans 4 years, with the latest figure at -$232000.0 for Q4 2025.

  • For Q4 2025, Income from Non-Controlling Interests rose 23.18% year-over-year to -$232000.0; the TTM value through Dec 2025 reached -$1.1 million, down 0.54%, while the annual FY2025 figure was -$1.1 million, 0.54% down from the prior year.
  • Income from Non-Controlling Interests for Q4 2025 was -$232000.0 at Fulgent Genetics, down from -$218000.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at -$46000.0 in Q3 2024 and bottomed at -$662000.0 in Q4 2021.
  • The 4-year median for Income from Non-Controlling Interests is -$302000.0 (2024), against an average of -$324230.8.
  • The largest YoY upside for Income from Non-Controlling Interests was 23.18% in 2025 against a maximum downside of 373.91% in 2025.
  • A 4-year view of Income from Non-Controlling Interests shows it stood at -$662000.0 in 2021, then skyrocketed by 33.84% to -$438000.0 in 2022, then soared by 31.05% to -$302000.0 in 2024, then grew by 23.18% to -$232000.0 in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Income from Non-Controlling Interests are -$232000.0 (Q4 2025), -$218000.0 (Q3 2025), and -$299000.0 (Q2 2025).